DANA-FARBER CANCER INSTITUTE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1947-01-01

Employees: -

Market Cap: -

Website: http://www.dana-farber.org/

Clinical Trials

Home Transfusion for HEME

Not Applicable

Recruiting

Conditions: Hematologic Malignancy

Interventions: Other: Home Transfusion Program Components

First Posted Date: 2022-08-22

Last Posted Date: 2024-12-03

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 20

Registration Number: NCT05509439

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2

Phase 2

Withdrawn

Conditions: Recurrent Metastatic Melanoma
Cutaneous Melanoma
Mucosal Melanoma
Uveal Melanoma

Interventions: Drug: Olaparib

First Posted Date: 2022-08-01

Last Posted Date: 2024-01-19

Lead Sponsor: Dana-Farber Cancer Institute

Registration Number: NCT05482074

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Recruiting

Conditions: Childhood Cancer Survivors
Adenomatous Hyperplasia
High-risk Oral Precancerous Diseases
Hereditary Cancer Prediction
IARC Carcinogens
Non-Alcoholic Fatty Liver Disease
High Grade Prostatic Epithelial Neoplasia
Serous Tubal Intraepithelial Carcinoma
Cervical and Endocervical Carcinoma in Situ
Nephrogenic Rests

Interventions: Other: Samples

First Posted Date: 2022-07-19

Last Posted Date: 2024-07-31

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 5000

Registration Number: NCT05463796

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

STAMP+CBT mHealth for Cancer Pain

Not Applicable

Recruiting

Conditions: Active Cancer
Active Cancer Treatment
Chronic Pain Due to Cancer
Advanced Cancer
Palliative Care

Interventions: Behavioral: STAMP+CBT application

First Posted Date: 2022-06-03

Last Posted Date: 2022-11-22

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 15

Registration Number: NCT05403801

Locations: 🇺🇸
Dana-Farber at Merrimack Valley, Methuen, Massachusetts, United States
🇺🇸
Dana-Farber at Londonderry, Londonderry, New Hampshire, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Early Interventional Treatment for Cancer Pain

Not Applicable

Active, not recruiting

Conditions: Cancer Pain

Interventions: Other: Early Referral
Other: Pain Management Strategies

First Posted Date: 2022-05-09

Last Posted Date: 2024-10-01

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 30

Registration Number: NCT05366413

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA)

Not Applicable

Recruiting

Conditions: Cancer
Insomnia Due to Medical Condition
Insomnia

Interventions: Behavioral: STEP-YA with Coaching
Behavioral: STEP-YA without Coaching

First Posted Date: 2022-05-03

Last Posted Date: 2024-03-21

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 74

Registration Number: NCT05358951

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial

Not Applicable

Recruiting

Conditions: Pancreatic Cancer

Interventions: Behavioral: Resistance Training (RT) and Protein Supplementation (PS)
Behavioral: Resistance Training (RT)
Behavioral: Attention Control (AC

First Posted Date: 2022-05-02

Last Posted Date: 2024-02-21

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 45

Registration Number: NCT05356117

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation

Not Applicable

Recruiting

Conditions: Mucosal Ulcer
Myeloablative Allogeneic Hematopoietic Cell Transplantation
Intraoral Photobiomodulation Therapy
Oral Mucositis

Interventions: Device: THOR LX2.3 with LED Lollipop

First Posted Date: 2022-04-19

Last Posted Date: 2024-11-05

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 20

Registration Number: NCT05335434

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy

Not Applicable

Recruiting

Conditions: Androgen Deprivation Therapy
Prostate Cancer
Prostate Cancer Metastatic

Interventions: Other: Aerobic and resistance exercise
Other: Usual Care

First Posted Date: 2022-04-14

Last Posted Date: 2024-01-23

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 62

Registration Number: NCT05327465

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study

Not Applicable

Recruiting

Conditions: Breast Cancer
Colorectal Cancer
Prostate Cancer

Interventions: Behavioral: Attention Control
Behavioral: Supervised Home-Based Exercise
Behavioral: Unsupervised Home-Based Exercise

First Posted Date: 2022-04-14

Last Posted Date: 2024-06-27

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 135

Registration Number: NCT05327452

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy